FDx Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
FDx Advisors's EXAS Position: Q1 2024 in Review
FDx Advisors sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 4,206 shares — an estimated $311K sold.
FDx Advisors first reported a position in EXAS in Q3 2016 and held it in 18 quarters. The position peaked at $987K in Q1 2022. 625 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.
- FDx Advisors reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
- FDx Advisors sold 4,206 Exact Sciences shares in Q1 2024, an estimated $311K.
- FDx Advisors first reported a position in Exact Sciences in Q3 2016 and held it in 18 quarters.
- FDx Advisors's Exact Sciences position peaked at $987K in Q1 2022.
- 625 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.
Based on FDx Advisors's 13F filing for Q1 2024, filed 3 May 2024.